Cargando…
Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity
Dapagliflozin, empagliflozin, tofogliflozin, selective inhibitors of sodium-glucose cotransporter 2 (SGLT2), is used clinically to reduce circulation glucose levels in patients with type 2 diabetes mellitus by blocking the reabsorption of glucose by the kidneys. Dapagliflozin is metabolized and inac...
Autores principales: | Okada, Junichi, Yamada, Eijiro, Saito, Tsugumichi, Yokoo, Hideaki, Osaki, Aya, Shimoda, Yoko, Ozawa, Atsushi, Nakajima, Yasuyo, Pessin, Jeffrey E., Okada, Shuichi, Yamada, Masanobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038111/ https://www.ncbi.nlm.nih.gov/pubmed/31979355 http://dx.doi.org/10.3390/molecules25030495 |
Ejemplares similares
-
Continuous or Transient High Level of Glucose Exposure
Differentially Increases Coronary Artery Endothelial Cell
Proliferation and Human Colon Cancer Cell Proliferation
por: Shimoda, Yoko, et al.
Publicado: (2017) -
Differences in the effects of Kenyan, Tanzanian, and Ethiopian coffee intake on interstitial glucose levels measured by FreeStyle Libre: A pilot case study
por: Okada, Junichi, et al.
Publicado: (2020) -
High Expression of Nucleobindin-2 Is Associated With Poor Prognosis in Gastric Cancer
por: Okada, Junichi, et al.
Publicado: (2021) -
Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM
por: Osaki, Aya, et al.
Publicado: (2019) -
FAM83G Is a Novel Inducer of Apoptosis
por: Okada, Junichi, et al.
Publicado: (2020)